1,134 material Form 8-K filings that 905 companies we cover made with the SEC in April 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
World Acceptance Corporation said President and CEO R. Chad Prashad resigned from his executive and board roles, effective April 10, 2026, to pursue other opportunities. The board appointed former CEO Janet L. Matricciani as interim president and CEO effective April 13, 2026, while it searches for a permanent successor. The leadership change is unplanned and the permanent CEO has not been named.
Prashad resigned as president, CEO and director effective April 10, 2026, to pursue other opportunities
Janet L. Matricciani named interim president and CEO effective April 13, 2026; the board has begun a search for a permanent CEO
Prashad's separation includes $1,260,000 in severance payable over 24 months and accelerated vesting of time-based equity awards
Matricciani's employment agreement provides a $83,333 monthly salary for 12 months and a $350,000 signing bonus
OGE Energy director Luther C. Kissam IV told the company on April 13, 2026 that he will resign from the Board at the annual shareholder meeting on May 14, 2026, citing a new chief executive role at another company. The company says the decision is not due to any disagreement over its operations, policies, or practices, and the board will shrink to eight directors at the meeting.
Director Luther C. Kissam IV will not stand for re-election and resigns effective at the May 14, 2026 Annual Meeting
Reason given: he recently accepted a chief executive officer position at another company, which requires him to leave other boards
Board size reduced from nine to eight directors effective with the Annual Meeting; the rest of the nominee slate is unchanged
APA Corporation released supplemental first-quarter 2026 figures ahead of full results, which it will discuss on a May 7 conference call. The company reported a $244 million net gain on oil and gas purchases and sales before tax, which includes a $66 million realized loss from commodity derivatives, and general and administrative expenses of $115 million. It also curtailed U.S. natural gas and natural gas liquids output in response to weak or negative Waha hub prices, and the filing gives no revenue or earnings per share figures.
Net gain on oil and gas purchases and sales was $244 million before tax, including a $66 million realized loss from commodity derivatives.
General and administrative expenses were $115 million, including about $25 million of higher-than-expected stock-based compensation tied to the share price increase.
APA curtailed about 88 MMcf/d of U.S. natural gas and 6,800 barrels per day of U.S. natural gas liquids production in the first quarter due to weak or negative Waha hub prices.
Full first-quarter 2026 results will be discussed on a conference call on Thursday, May 7, at 10 a.m. Central Time.
Meta said directors Hock E. Tan and Tracey T. Travis notified the company on April 8, 2026 that they will not stand for re-election to the Board at the 2026 Annual Meeting of Shareholders. Both will remain directors until that meeting, so the board has no immediate vacancy.
Notice given on April 8, 2026 by Hock E. Tan and Tracey T. Travis
Neither director will stand for re-election at the 2026 Annual Meeting of Shareholders
Both will continue serving as directors until the Annual Meeting date
Concentra Group Holdings Parent, Inc. said Executive Vice President and Chief Medical Officer Dr. John Anderson will retire effective December 31, 2026. The company has started a formal search for his successor and expects to enter a consulting agreement with him to support the transition. The filing includes no financial results or guidance.
Dr. John Anderson notified the company of his retirement on April 10, 2026, effective December 31, 2026.
The company has initiated a formal search for Anderson's successor.
The company expects to enter a Consulting Agreement with Anderson to support the transition of his responsibilities.
Anderson joined Concentra in 1993 and has served as Chief Medical Officer since 2014.
Quaker Houghton signed Amendment No. 4 to its credit agreement on April 10, 2026, with Bank of America, N.A. as administrative agent. The new facilities include a $550 million U.S. dollar term loan, a $250 million euro-equivalent term loan and an $800 million revolving credit facility, which will repay the existing loans and replace the prior revolving commitments. The filing says the amendment extends the nearest debt maturity to 2031 and increases available credit, but the new debt is secured by first priority liens on substantially all company and guarantor assets and includes covenants that limit dividends and share repurchases.
Amended Credit Agreement signed April 10, 2026; all debt outstanding matures April 10, 2031
New facilities: $550 million U.S. dollar term loan, $250 million euro-equivalent term loan, $800 million revolving credit facility
Proceeds repay in full all outstanding loans under the existing credit agreement and terminate its revolving commitments
Debt is secured by first priority liens on substantially all assets of the Company and subsidiary guarantors
Prudential Financial disclosed preliminary, unaudited first-quarter 2026 figures ahead of its May 5, 2026 earnings release. It estimates alternative investment income from its General Account portfolio was $75-95 million below near-term expectations, and it also changed its segment reporting, effective January 1, 2026, to add U.S. Legacy Products and Retirement segments. The company has not completed its closing procedures, so final results could differ materially.
Alternative investment income of the General Account portfolio is estimated at $75-95 million below near-term expectations for the quarter ended March 31, 2026.
PGIM assets under management were $1.43 trillion as of March 31, 2026, and PGIM other related revenues, net of related expenses, were approximately $35 million on an adjusted operating income basis.
Segment changes effective January 1, 2026 create a U.S. Legacy Products segment and a Retirement segment; prior periods are restated retrospectively.
Full first-quarter results are scheduled for release on May 5, 2026.
Range Resources said it expects a total loss on derivatives of $33.4 million for the three months ended March 31, 2026. It also expects net cash payments on derivative settlements of $49.3 million for the period, mainly from natural gas contracts. The amounts are preliminary and will be finalized in the Form 10-Q or the corresponding earnings release.
Expected total loss on derivatives: $33.4 million for the three months ended March 31, 2026
Expected total net cash payment on derivative settlements: $49.3 million
Natural gas derivatives accounted for a $41.4 million cash payment; natural gas basis derivatives $4.2 million; oil derivatives $3.6 million
Figures are preliminary and subject to change; final amounts to be reported in the Form 10-Q or earnings release
EQT Corporation said in an 8-K filed April 14, 2026 that it expects a total loss on derivatives of $238 million for the three months ended March 31, 2026. It also expects net cash settlements paid on derivatives of $304 million for the period, including $114 million on NYMEX natural gas hedges and $190 million on basis and liquids hedges. The figures are preliminary and will be finalized in its first-quarter Form 10-Q or earnings release.
Expected total loss on derivatives of $238 million for the three months ended March 31, 2026
Expected net cash settlements paid on derivatives of $304 million, including $114 million on NYMEX natural gas hedges and $190 million on basis and liquids hedges
No premiums paid or received for derivatives that settled during the period
Dollar amounts are preliminary and subject to change; final figures to be reported in the Form 10-Q or earnings release
Hershey said Andrew Archambault, its President, US, will leave the company effective May 1, 2026. The company has begun a search for his replacement, and the filing gives no reason for the departure or any details on a successor.
Andrew Archambault, President, US, will leave the company effective May 1, 2026.
The company has begun a search for his replacement.
The filing does not state a reason for the departure or name an interim successor.
Procter & Gamble's Board declared a quarterly dividend of $1.0885 per share, which the company says is a three percent increase over the prior quarterly dividend. The dividend is payable on or after May 15, 2026, to common shareowners of record on April 24, 2026. The company says it has increased its dividend for 70 consecutive years.
Quarterly dividend of $1.0885 per share, a three percent increase over the prior quarterly dividend
Payable on or after May 15, 2026; common shareowner record date is April 24, 2026
Company says it has paid a dividend for 136 consecutive years and increased it for 70 consecutive years
SPS Commerce amended all outstanding performance stock unit awards held by its executive officers, including retired executives, to a single revised PSU Agreement effective April 10, 2026. The change makes treatment of 2024 awards consistent with 2025 and 2026 awards, and the new agreement will also apply to future grants.
Effective date of the amended PSU Agreement is April 10, 2026
2024 PSUs had single-trigger vesting; 2025 and 2026 PSUs had double-trigger vesting
Under the new agreement, accelerated vesting generally requires termination without cause or good-reason resignation within one year after a change in control, or the surviving entity failing to continue or assume the awards
Phibro Animal Health director Joyce J. Lee informed the company on April 13, 2026 that she intends to resign from the Board effective April 15, 2026. The filing states her resignation was not due to any disagreement with the company on its operations, policies or practices.
Joyce J. Lee, a Class II Director, intends to resign effective April 15, 2026
Notice was given to the company on April 13, 2026
Filing states no disagreement with the company on operations, policies or practices
On April 14, 2026, CoreWeave completed two private debt offerings to qualified institutional buyers: $1.75 billion of 9.750% Senior Notes due 2031 and $4 billion of 1.75% Convertible Senior Notes due 2032, including a $500 million option exercised in full. CoreWeave says it will use the senior note proceeds for general corporate purposes, including repaying existing indebtedness. The convertible notes can be settled in cash, Class A shares, or a mix, at CoreWeave's election, which could add up to 43,478,000 shares to the share count if converted at the maximum rate.
Senior Notes: $1.75 billion, 9.750% coupon, mature October 1, 2031, interest paid April 1 and October 1 starting October 1, 2026
Convertible Notes: $4 billion including a $500 million option exercised in full, 1.75% coupon, mature October 1, 2032
Initial conversion price of about $119.60 per share, a 30.0% premium to the April 9, 2026 last reported sale price
Convertible notes cannot be redeemed before October 8, 2029; maximum conversion would issue up to 43,478,000 Class A shares
Otter Tail Corporation's board elected Tim Rogelstad as President and Tyler Nelson as Vice President and Chief Financial Officer, both effective April 13, 2026, as part of a long-term succession plan. Former CFO Todd Wahlund became Senior Vice President and President of Otter Tail Power Company, and CEO Charles MacFarlane remains CEO after stepping down as President. The filing discloses no financial results, and the changes are presented as planned succession rather than a response to performance.
Tim Rogelstad, 59, elected President on April 13, 2026; previously President of Otter Tail Power Company since 2014
Tyler Nelson, 46, elected Vice President and CFO on April 13, 2026; previously Vice President of Finance and Treasurer
Todd Wahlund stepped down as CFO and was elected Senior Vice President and President of Otter Tail Power Company
Nelson's base salary is $465,000, with a 50% annual cash incentive target and $250,000 long-term incentive target
JPMorgan Chase reported first-quarter 2026 results in an investor presentation furnished under Item 7.01. Net income was $16.5 billion, up 13% from a year earlier, and diluted EPS was $5.94 versus $0.87 in the first quarter of 2025, while managed revenue rose 10% to $50.5 billion. The filing also reaffirms a full-year 2026 outlook of about $103 billion in net interest income, market dependent.
Net income of $16.5 billion, up 13% year over year; diluted EPS of $5.94 compared with $0.87 a year earlier
Managed revenue of $50.5 billion, up 10% year over year; expense of $26.9 billion, up 14%
Common dividend of $4.1 billion, or $1.50 per share, plus $8.1 billion of net common stock repurchases in the quarter
FY2026 outlook: net interest income of about $103 billion, market dependent; adjusted expense of about $105 billion
Citigroup reported first-quarter 2026 net income of $5.8 billion, or $3.06 per diluted share, up from $4.1 billion, or $1.96 per diluted share, a year earlier, on revenue of $24.6 billion, up 14%. The company returned approximately $7.4 billion to common shareholders through share repurchases and dividends, while its CET1 capital ratio fell to 12.7% from 13.2% in the prior quarter.
Net income of $5.8 billion and diluted EPS of $3.06, versus $4.1 billion and $1.96 in Q1 2025
Revenues of $24.6 billion, up 14% year over year, with Services up 17% and Markets up 19%
Approximately $7.4 billion returned to common shareholders in share repurchases and dividends during the quarter
CET1 capital ratio of 12.7% (preliminary), down from 13.2% at year-end 2025; total non-accrual loans rose 25% to $3.4 billion
Corteva named Luke Kissam, former Albemarle chairman, president and CEO, as CEO of New Corteva, the crop protection company that will separate from its seed business, SpinCo, in the fourth quarter of 2026. Kissam joins the company June 1, 2026, and Chief Executive Chuck Magro will become SpinCo CEO at separation, with new executive teams named for both companies. The filing discloses no financial results; the changes set the leadership structure for the planned separation.
Luke Kissam, 61, joins June 1, 2026 as CEO of the Crop Protection Business Unit and becomes New Corteva CEO at separation.
Kissam's employment agreement sets a $1.2 million annual base salary, a 150% short-term incentive target, and a one-time 2026 equity award with a $3.75 million target grant date value.
Jeff Rudolph is named New Corteva CFO; David Johnson becomes SpinCo CFO; Magro becomes SpinCo CEO.
Robert King, Executive Vice President of Crop Protection, becomes a strategic advisor July 1, 2026, and leaves after 2026 year-end, eligible for a $1 million transition bonus.
TransDigm Group furnished unaudited preliminary results for the thirteen weeks ended March 28, 2026, with net sales of about $2,540 million to $2,545 million and EBITDA As Defined of about $1,330 million to $1,335 million. It also said subsidiary TransDigm Inc. plans, subject to market conditions, to raise $1.25 billion of new debt, with proceeds used to fund the Stellant Systems acquisition and about $800 million of share repurchases completed in March 2026.
Preliminary net sales of approximately $2,540 million to $2,545 million for the thirteen weeks ended March 28, 2026, unaudited
Preliminary EBITDA As Defined of approximately $1,330 million to $1,335 million, subject to final closing procedures
Planned offering of $250 million of 6.125% senior subordinated notes due 2034 and up to $1,000 million of new tranche N term loans
Proceeds, with cash on hand, to fund the Stellant Systems purchase price and about $800 million of share repurchases completed in March 2026
Marsh & McLennan said Mark McGivney, its Chief Financial Officer, will also become Executive Vice President and Chief Operating Officer, effective April 15, 2026. He will lead the company's inorganic strategies and support CEO John Doyle, while the Marsh Executive Committee continues to report to Doyle.
Base salary of $1,250,000 effective April 15, 2026
Target annual bonus of $3,450,000 starting with the 2026 performance year, awarded in February 2027
Target long-term incentive award of $6,300,000 starting with the 2027 award, plus a $10 million stock unit grant on May 1, 2026 vesting in three equal annual installments beginning May 15, 2027
Harmony Biosciences said CFO Sandip Kapadia stepped down effective April 14, 2026, to pursue other career opportunities, and named Glenn Reicin as his successor effective the same day. The company also reiterated its 2026 net product revenue guidance of $1.0 to $1.04 billion, so the change does not come with a guidance change.
Sandip Kapadia left the CFO role effective April 14, 2026; his separation agreement provides severance under his existing employment and award agreements, in exchange for a release of claims.
Glenn Reicin, age 61, was appointed CFO effective April 14, 2026; he was CFO at Eccogene from October 2024 to October 2025.
Reicin's employment agreement sets a $500,000 annual base salary, a target bonus of 50% of base salary, and an option award with a $3,000,000 grant date fair value vesting over four years.
Harmony reiterated its 2026 net product revenue guidance of $1.0 to $1.04 billion, primarily from WAKIX sales.
Amazon.com and Globalstar signed a definitive merger agreement under which Amazon will acquire Globalstar, adding direct-to-device satellite services to Amazon Leo. The deal is subject to closing conditions including regulatory approvals, and the filing says it is expected to close in 2027, so shareholders face a multi-year transaction with terms that depend on stock prices and milestones.
Globalstar holders can elect $90.00 in cash or 0.3210 Amazon shares per share, with the stock value capped at $90.00
Cash elections are capped at 40% of Globalstar shares, with excess cash converted to stock on a pro rata basis
Total consideration may be reduced by up to $110 million if Globalstar misses certain operational milestones
Holders of about 58% of Globalstar's voting power approved the deal by written consent; Amazon also signed a satellite services agreement with Apple
Johnson & Johnson reported first-quarter 2026 reported sales of $24.1 billion, up 9.9%, and raised its full-year 2026 guidance, with estimated reported sales of $100.8 billion at the midpoint. Net earnings fell 52.4% to $5.2 billion, and the prior-year quarter included a large litigation-related gain, while adjusted EPS declined 2.5% to $2.70. The board also raised the quarterly dividend 3.1% to $1.34 per share.
Reported sales rose 9.9% to $24.1 billion; U.S. sales rose 8.3% to $13.3 billion.
Net earnings were $5.2 billion, or $2.14 per diluted share, versus $11.0 billion, or $4.54, a year earlier.
Adjusted EPS was $2.70 versus $2.77; 2026 adjusted EPS guidance midpoint is $11.55, up from $11.53 in January.
Quarterly dividend rises to $1.34 from $1.30; ex-dividend date is May 26, 2026, payable June 9, 2026.
Albertsons reported a fourth-quarter net loss of $480.8 million, or $0.94 per share, after a $599.8 million after-tax charge tied to a $774 million opioid settlement framework payable over nine years. Excluding the charge and other adjustments, fourth-quarter adjusted net income rose to $251.7 million, or $0.48 per share, from $0.46 a year earlier, and the board raised the quarterly dividend 13% and expanded the buyback authorization.
Q4 fiscal 2025 net loss of $(480.8) million, or $(0.94) per share, versus net income of $171.8 million, or $0.29 per share, a year earlier; adjusted net income was $251.7 million, or $0.48 per share.
Opioid Settlement Framework totals about $774 million over nine years; first payment expected April 30, 2026 into escrow; after-tax net present value of about $482 million; subject to participation by states, political subdivisions and trib
Quarterly dividend raised 13% to $0.17 per share from $0.15, payable May 8, 2026 to holders of record as of April 24, 2026; remaining share repurchase authorization increased by $900 million to $2.0 billion.
Fiscal 2026 outlook: adjusted EBITDA of $3.850 billion to $3.925 billion and adjusted net income per share of $2.22 to $2.32, compared with $2.18 in fiscal 2025.
CarMax reported a fourth-quarter fiscal 2026 net loss of $120.7 million, or $0.85 per diluted share, compared with earnings of $89.9 million, or $0.58 per share, a year earlier. The loss reflects a non-cash goodwill impairment of $141.3 million, and total gross profit fell 9.4% to $605.3 million on lower revenue of $5.95 billion, down 1.0%. Excluding the impairment and restructuring charges, adjusted EPS was $0.34 versus $0.64 a year ago.
Q4 net loss of $120.7 million, or $0.85 per diluted share, versus earnings of $0.58 per share a year earlier
Goodwill impairment of $141.3 million; adjusted EPS of $0.34 versus $0.64 a year earlier
Total gross profit down 9.4% to $605.3 million; retail used gross profit per unit down $207 to $2,115
Targeted SG&A savings raised to $200 million by end of fiscal 2027 from $150 million; Keith Barr became CEO effective March 16, 2026; share repurchases paused in Q4 after $50.4 million
LeMaitre Vascular director Bridget Ross notified the board on April 8, 2026 that she will not stand for re-election at the June 2, 2026 annual meeting, and she will serve until then. The board nominated David B. Roberts for a Class II seat to rebalance board classes; he conditionally resigned his Class I seat, and the board will shrink from eight to seven members. The filing describes these changes as administrative and states no disagreements with the company.
Bridget Ross, Class II director, notified the board on April 8, 2026 of her intent not to stand for re-election
David B. Roberts nominated as Class II director; he notified the board on April 9, 2026 of his conditional resignation as a Class I director
Board size reduced from eight to seven members, effective upon Ross's departure; board to have two Class I, two Class II and three Class III directors
BlackRock reported first-quarter 2026 results on April 14, 2026, with total revenue of $6.7 billion, up 27% from $5.3 billion a year earlier but down from $7.0 billion in the fourth quarter of 2025. GAAP diluted EPS was $14.06 versus $9.64 a year earlier, and as adjusted diluted EPS was $12.53, up 11% from $11.30, though below $13.16 in the prior quarter. Headline year-over-year measures improved, and the company also raised its quarterly dividend 10%.
Total revenue was $6.7 billion, up 27% from $5.3 billion in Q1 2025 and down from $7.0 billion in Q4 2025.
GAAP diluted EPS was $14.06 versus $9.64 a year earlier; as adjusted diluted EPS was $12.53 versus $11.30.
Quarterly net inflows were $130 billion, and net inflows were $744 billion over the last twelve months.
Quarterly cash dividend rose 10% to $5.73 per share, and the company repurchased $450 million of shares in the quarter.
Dow's Board appointed Chief Operating Officer Karen S. Carter as Chief Executive Officer effective July 1, 2026, and added her as a director. Current Chair and CEO Jim Fitterling will become Executive Chair on the same date. Stockholders approved all five agenda items at the April 9, 2026 annual meeting, including an increase in shares available under the 2019 Stock Incentive Plan from 125 million to 185 million.
Karen S. Carter, 55, succeeds Jim Fitterling as CEO effective July 1, 2026; Carter has been COO since December 2024
Fitterling remains an employee and becomes Executive Chair; Richard K. Davis continues as Independent Lead Director
Stockholders approved the Plan amendment with 76% of votes cast in favor; all twelve director nominees were re-elected
Board declared a quarterly dividend of 35 cents per share, payable June 12, 2026 to holders of record on May 29, 2026
JPMorgan Chase reported first-quarter 2026 net income of $16.5 billion, or $5.94 per diluted share, up from $14.6 billion, or $5.07 per share, a year earlier. Reported net revenue rose 10% to $49.8 billion, and the firm repurchased $8.1 billion of common stock and paid a $1.50 per share dividend, which supports shareholder returns.
Net income of $16.5 billion, up 13% from $14.6 billion in first-quarter 2025; diluted EPS of $5.94 vs. $5.07
Reported net revenue of $49.8 billion, up 10%; noninterest expense of $26.9 billion, up 14%
Provision for credit losses of $2.5 billion, down 24% from $3.3 billion a year earlier
Common dividend of $1.50 per share ($4.1 billion) and $8.1 billion of common stock net repurchases
Wells Fargo reported first quarter 2026 net income of $5.3 billion, or $1.60 per diluted share, up from $1.39 a year earlier, on total revenue of $21.4 billion, up 6%. Compared with the fourth quarter of 2025, net income fell 2% and diluted EPS fell from $1.62, and the CET1 ratio was 10.3%, down from 11.1% a year earlier. The company also repurchased $4.0 billion of common stock during the quarter.
Total revenue was $21.4 billion, up 6% from the first quarter of 2025 and up 1% from the fourth quarter of 2025.
Diluted EPS of $1.60 was up 15% from a year earlier but down from $1.62 in the fourth quarter of 2025.
The quarter included a $135 million, or $0.04 per share, discrete tax benefit tied to prior period matters.
Wells Fargo repurchased 46.3 million shares, or $4.0 billion, of common stock in the quarter; the CET1 ratio was 10.3%, a preliminary estimate.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.